-
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the…
-
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes. This milestone reflects the Company’s long-range quality strategy focused on sustained compliance, continuous audit readiness, and operational effectiveness. Through robust governance, quality culture initiatives, workforce development, and…
-
Maiva Pharma Inaugurates New State-of-the-Art Sterile Injectable Manufacturing Facility at Shoolagiri, India
Six manufacturing lines to enable production of diverse sterile injectable formats, from vials and pre-filled syringes to cartridges, suspensions and lyophilized formulations Bengaluru, Karnataka, India Maiva Pharma, a leading global Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) specialising in sterile injectables, today inaugurated its new manufacturing facility at Shoolagiri, Tamil Nadu,…
-
Patton Awarded Subcontract to Develop Source-Secure Fiber Optic Modules for U.S. Defense Applications
“This award reflects the growing importance of trusted, domestic supply chains in national security systems.” Bryan DuboisV.P. Special ProjectsPATTON GAITHERSBURG, Md., June 10, 2026 (GLOBE NEWSWIRE) — Patton®—a US-based electronics developer and provider of contract engineering and manufacturing services—today announced it has been awarded a subcontract to develop specialized, source-secure fiber optic transport modules in…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
-
Sword Group: Strategic contract with eu-LISA
Sword Group | eu-LISA framework contract awarded to leading consortium Sword ranked first in a €93 million contract for the EU Entry/Exit System Sword Services Greece, leading a consortium alongside Netcompany and Sopra Steria, has been ranked first and awarded a contract under eu-LISA’s Dynamic Purchasing System for the development and maintenance of the Entry/Exit…
-
Morepen Bags Rs. 825 Crore Global Deal
Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major. Morepen Bags Rs. 825 Crore Global Deal, Expands into High-Growth CDMO Segment Supplies under the mandate are expected to commence within the…
-
Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21% Adj EBITDA Growth
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26. Q3 FY 26 saw strong performance across its key business segments. CDMO saw a revenue growth of over 16% spurred on by double digit increase in volumes. The…
-
Balu Forge Industries Ltd Secures Major Order for 152mm Artillery Shells; Accelerates Forward Integration in Defence Sector
Balu Forge Industries Ltd (BSE: 531112 | NSE: BALUFORGE), a leading precision engineering and manufacturing company, is pleased to announce the receipt of a significant order in the large-calibre ammunition segment. The company has secured an initial contract to supply 30,000 units of 152 mm artillery shells to a major Indian energetics player. This partnership…
-
Gastops FluidSIGHT™ Awarded IDEaS Test Drives Contract Under Canada’s All Systems Go! Challenge
OTTAWA, ON, May 28, 2026 /PRNewswire/ — Gastops, a Canadian leader in intelligent condition monitoring and maintenance solutions, today announced it has been awarded a contract for FluidSIGHT™ under Canada’s Innovation for Defence Excellence and Security (IDEaS) program as a Test Drives participant in the All Systems Go! challenge. Test Drives enable the Department of National Defence (DND) and…
-
Dudigital Global Limited Secures CPV Services Contract from Embassy of India, Kuwait
3-year contract strengthens recurring revenue visibility and expands GCC presence New Delhi, Delhi, India Dudigital Global Limited today announced that it has been awarded the contract for outsourcing of Consular, Passport and Visa services by the Embassy of India, Kuwait, following a two-stage competitive bidding process. The contract is valid for a period of three…
-
Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Dividend
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), announced its financial results for the fourth quarter and the full year ended March 31, 2026. The company delivered a steady performance during Q4 FY26, with healthy revenue growth and improved operating profitability driven by its core domestic…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
